Lewis H. Titterton Jr., Director at Anixa Biosciences Inc (ANIX), bought 3,000 shares at $2.91 ($9K) on 2025-01-23, disclosed to the SEC on 2025-01-27.
Open-market purchase of $9k ANIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.91 | 2,000 | $6K | 66.0% |
| 2 | $3.00 | 1,000 | $3K | 34.0% |
| Total | $2.94 avg | 3,000 | $9K | 100% |
| Filing → |
| ANIX | BUY | 2026-07-20 | $42K | — | Filing → |
| ANIX | BUY | 2026-07-16 | $9K | — | Filing → |
| ANIX | BUY | 2026-06-17 | $7K | — | Filing → |